These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 25181691)

  • 1. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
    Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
    Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
    Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
    mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
    Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
    Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
    Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.
    Wang Y; Chen G; Pan Q; Zhao J
    Gastroenterology; 2018 Mar; 154(4):1199-1201. PubMed ID: 29432746
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
    Klein F; Neuhaus R; Hofmann J; Rudolph B; Neuhaus P; Bahra M
    Exp Clin Transplant; 2015 Jun; 13(3):283-6. PubMed ID: 24779678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Case Genotype 4 Hepatitis E Infection After a Liver Transplant.
    Wu CH; Ho CM; Tsai JH; Sun HY; Hu RH; Lee PH
    Exp Clin Transplant; 2017 Apr; 15(2):228-230. PubMed ID: 26221721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.
    Galante A; Pischke S; Polywka S; Luetgehethmann M; Suneetha PV; Gisa A; Hiller J; Dienes HP; Nashan B; Lohse AW; Sterneck M
    Transpl Infect Dis; 2015 Aug; 17(4):617-22. PubMed ID: 26094550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
    Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
    Chen S; Wei F; Wu T; Xia N
    Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.
    Goyal R; Kumar A; Panda SK; Paul SB; Acharya SK
    Antivir Ther; 2012; 17(6):1091-6. PubMed ID: 22910532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
    Haldipur B; Bhukya PL; Arankalle V; Lole K
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse.
    Abravanel F; Lhomme S; Rostaing L; Kamar N; Izopet J
    Clin Infect Dis; 2015 Jan; 60(1):96-9. PubMed ID: 25249523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience.
    Pischke S; Hardtke S; Bode U; Birkner S; Chatzikyrkou C; Kauffmann W; Bara CL; Gottlieb J; Wenzel J; Manns MP; Wedemeyer H
    Liver Int; 2013 May; 33(5):722-6. PubMed ID: 23489973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.
    Lhomme S; Kamar N; Nicot F; Ducos J; Bismuth M; Garrigue V; Petitjean-Lecherbonnier J; Ollivier I; Alessandri-Gradt E; Goria O; Barth H; Perrin P; Saune K; Dubois M; Carcenac R; Lefebvre C; Jeanne N; Abravanel F; Izopet J
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1608-14. PubMed ID: 26711757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients.
    Kamar N; Lhomme S; Abravanel F; Cointault O; Esposito L; Cardeau-Desangles I; Del Bello A; Dörr G; Lavayssière L; Nogier MB; Guitard J; Ribes D; Goin AL; Broué P; Metsu D; Sauné K; Rostaing L; Izopet J
    Transplantation; 2015 Oct; 99(10):2124-31. PubMed ID: 26214817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.